# Simvastatin Augmentation of Lithium Treatment in Bipolar Depression

> **NCT01665950** · PHASE2 · TERMINATED · sponsor: **Massachusetts General Hospital** · enrollment: 4 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** Simvastatin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01665950
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-08
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Lack of enrollment
- **Last updated:** 2017-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01665950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01665950, "Simvastatin Augmentation of Lithium Treatment in Bipolar Depression". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01665950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*